For patients with severe hypertension that remains uncontrolled despite medical therapy, radiofrequency (RF) energy can ...
Hypertension
This page includes news and new technology on hypertension. The condition is caused by abnormally high blood pressure that causes excess force and pressure of the blood against the artery walls. Long-term, this can cause damage the vessels and contributes to heart disease. Therapies include antihypertensive medications such as diurestics and renal denervation therapy.
November 22, 2010 – Data presented at the American Heart Association’s Scientific Sessions 2010 showed that ...
October 20, 2010 - The U.S. Food and Drug Administration (FDA) approved a new drug to help prevent stroke and ...
October 15, 2010 – The U.S. Food and Drug Administration (FDA) has approved an abbreviated new drug application ...
October 7, 2010 - Taking medication at night instead of in the morning significantly increases efficacy in ...
September 29, 2010 - Preclinical data of a therapy designed to treat drug-resistant hypertension was presented ...
August 30, 2010 – According to the results of a late-breaking analysis involving more than 200 000 patients in ...
August 18, 2010 - The U.S. Food and Drug Administration (FDA) today proposed to withdraw approval of the drug ...
July 1, 2010 – Clinical results have shown the Rheos System is successful in lowering blood pressure, CVRx Inc ...
June 21, 2010 – Long-term data presented today from Ardian’s Symplicity HTN-1 study demonstrate that the ...
June 15, 2010 – Health care professionals can now get information on the diagnosis, pathology, and treatment of ...
April 22, 2010 — An improved formulation of epoprostenol for the treatment of primary pulmonary arterial ...
April 19, 2010 – The U.S. Food and Drug Administration (FDA) recently cleared a generic version of metoprolol ...
March 23, 2010 – The FDA granted approval for diltiazem hydrochloride extended-release tablets to treat ...
March 16, 2010 — Lowering blood pressure to normal levels — below currently recommended levels — did not ...